Fact CheckerSign in

NCT06916520Active, not recruitingPhase 4

PROMOTE

Prasugrel Monotherapy Reduced dose in Acute and Chronic Coronary Syndrome Patients after Percutaneous Coronary Intervention

Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Oct 2025

Brief summary (registry, in English)

This study will assess the feasibility and safety of a single antiplatelet strategy with a reduced dose of prasugrel 5 mg after percutaneous coronary intervention in acute and chronic coronary syndrome patients.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
300 (estimated)
First submitted
4 Apr 2025
Start date
13 Nov 2025
Lead sponsor
Amsterdam UMC Stichting
NCT number
NCT06916520
EU CT number
2024-520351-24-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 300
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current indication for oral anticoagulant therapy (OAC)
  • Participation in another trial with an investigational drug or device

Other illness

  • Known allergy or contraindication for prasugrel (including active pathological bleeding, severe liver disease (defined as Child Pugh class C))

Other

  • Indication for ongoing DAPT (e.g. PCI ≤ 6 months for CCS or ACS ≤ 12 months)
  • Pregnancy or breast-feeding women
  • Recent or ongoing use of CYP2B6 substrates with a narrow therapeutic window

Who the study is looking for

  • Acute coronary intervention
  • Chronic coronary syndrome
  • Successfull PCI (according tot treating physician)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Amsterdam UMC Stichting
Coordinator of this site? Confirm its status
AmsterdamNetherlandsActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.